"We screened the Investors Business Daily (IBD) and Zacks databases to find companies whose earnings are accelerating and whose earnings estimates are being increased by analysts," says J. Royden Ward.

The editor of the Cabot Benjamin Graham Value Letter continues, "All of the stocks in our list have IBD Composite Ratings of 95 (99 is best) and Zacks Ratings of 1 or 2 (1 is best). These recommendations offer excellent appreciation potential with moderate risk.

Continue reading Ben Graham-Style Techs with Rising Estimates

Ben Graham-Style Techs with Rising Estimates originally appeared on BloggingStocks on Tue, 08 Mar 2011 11:00:00 EST. Please see our terms for use of feeds.

"The Canadian economy performed much better than the U.S. economy during the past two and a half years," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "We believe many outstanding buying opportunities still exist and investors should continue to buy undervalued Canadian stocks."

Here, he looks at a trio of Canadian-based resource plays: Barrick Resources (ABX), Pan American Silver (PAAS), and Teck Resources 'B' (TCK).

Continue reading Canadian Resource Trio: Ben Graham Value Buys?

Canadian Resource Trio: Ben Graham Value Buys? originally appeared on BloggingStocks on Wed, 12 Jan 2011 10:30:00 EST. Please see our terms for use of feeds.

This post is one in a series in which more than 60 newsletter advisors share their Top Stock Picks for 2011. This special report is courtesy of TheStockAdvisors.com.

"Arrow Electronics (ARW) s a classic value stock with low price-to-earnings and price-to-book value ratios. Founded in 1935 and based in Melville, New York," notes J. Royden Ward.

The editor of the Cabot Benjamin Graham Value Letter explains, "Arrow is the second largest distributor of electronic components and computer products, serving 900 suppliers throughout North America, Europe and Asia.

Continue reading Top Picks 2011: Arrow Electronics (ARW)

Top Picks 2011: Arrow Electronics (ARW) originally appeared on BloggingStocks on Tue, 28 Dec 2010 13:00:00 EST. Please see our terms for use of feeds.

"Quality companies with low price-to-book value ratios (P/BV) have outperformed companies with higher valuations for the past three-, five- and 10-year periods," says J. Royden Ward.

The editor of the Cabot Benjamin Graham Value Letter explains, "Our search for undervalued companies to with price to book value ratios found three stocks in tech-related sectors: Kyocera (KYO), PC Connection (PCCC), and Thermo Fisher Scientific (TMO).

"To find the best stocks with low price-to-book value ratios, we required Value Line Financial Strength ratings of A or better, dividend payments increasing over time, low P/E ratios and good earnings prospects for the next 12-month and five-year periods.

Continue reading Ben Graham Techs? A Trio of Low P/E-to-Book Value Buys

Ben Graham Techs? A Trio of Low P/E-to-Book Value Buys originally appeared on BloggingStocks on Tue, 30 Nov 2010 10:30:00 EST. Please see our terms for use of feeds.

"Research In Motion (RIMM) is clearly undervalued at 9.7 times forward EPS; investor's concerns regarding the intense competition in the smart phone market have caused the stock price to decline 26% during the past seven months," says value investor J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "We believe exciting new product introductions will boost sales and earnings growth more than expected during the next couple of years.

Continue reading Research In Motion (RIMM): A 'Ben Graham' Value Buy

Research In Motion (RIMM): A 'Ben Graham' Value Buy originally appeared on BloggingStocks on Wed, 17 Nov 2010 10:30:00 EST. Please see our terms for use of feeds.

The editor of Cabot Benjamin Graham Value Letter explains, "Gilead is a biopharmaceutical company that discovers, develops and markets therapeutic treatments to combat viral, bacterial and fungal infections. Its shares undervalued at 9.7 times forward 12-month EPS.

"Teva, based in Israel, develops, makes and sells generic and proprietary-branded (store brand) drugs. Its shares are clearly undervalued at 10.6 times forward EPS. We consider both stocks to be very low risk.

Continue reading Ben Graham Buys in Pharma: Gilead (GILD) and Teva (TEVA)

Ben Graham Buys in Pharma: Gilead (GILD) and Teva (TEVA) originally appeared on BloggingStocks on Thu, 14 Oct 2010 11:00:00 EST. Please see our terms for use of feeds.

"Benjamin Graham has been recognized for decades as the father of value investing; Warren Buffett is known as the Oracle of Omaha for his superior investing skills," asserts J. Royden Ward, adding, "For this report, we combine Warren Buffett's and Ben Graham's criteria for choosing stocks.

The advisor reviews Abbott Laboratories (ABT), Coach (COH), Intel (INTC), Mastercard (MA), Microsoft (MSFT) and Tupperware Brands (TUP).

Continue reading Graham/Buffett Buys: A Six-Pack of Values

Graham/Buffett Buys: A Six-Pack of Values originally appeared on BloggingStocks on Mon, 20 Sep 2010 10:30:00 EST. Please see our terms for use of feeds.

"Investing in conservative stocks to build or rebuild the core of your portfolio makes sense right now; investors should buy companies that have a long history of steady earnings and dividend growth, through good times and tough times," says J. Royden Ward.

The editor of the specialty newsletter, Cabot Benjamin Graham Value Letter, explains, "The obvious benefit of adhering to a disciplined system of value investing like ours is that you build long-term profits and, ideally, financial independence.

Continue reading Ben Graham Values: Ten Conservative Growth and Income Ideas

Ben Graham Values: Ten Conservative Growth and Income Ideas originally appeared on BloggingStocks on Wed, 28 Jul 2010 10:00:00 EST. Please see our terms for use of feeds.

"The stock market is now below the midpoint of fair valuation, a fact that leads us to believe there is further upside for the market ahead," says J. Royden Ward, who specializes in uncovering value-oriented investments.

The editor of Cabot Benjamin Graham Value Letter explains, "Our goal is to identify value and one such value, in our view, is Wal-Mart Stores (WMT), the world's largest retailer, employing more than two million workers in more than 7,500 stores.

Continue reading Wal-Mart Stores (WMT): A Ben Graham Value?

Wal-Mart Stores (WMT): A Ben Graham Value? originally appeared on BloggingStocks on Thu, 08 Jul 2010 13:30:00 EST. Please see our terms for use of feeds.

Continue reading SkyWest (SKYW): A Classic Ben Graham Value Stock

SkyWest (SKYW): A Classic Ben Graham Value Stock originally appeared on BloggingStocks on Tue, 04 May 2010 10:40:00 EST. Please see our terms for use of feeds.

Continue reading 'Ben Graham' Buys: Six-Pack of Foreign Value Stocks

'Ben Graham' Buys: Six-Pack of Foreign Value Stocks originally appeared on BloggingStocks on Mon, 19 Apr 2010 12:00:00 EST. Please see our terms for use of feeds.

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

J. Royden Ward is the editor of The Cabot Benjamin Graham Value Letter, a newsletter that -- as its name suggests -- focuses on stocks that meet the criteria of legendary value investor Ben Graham.

For his top pick for 2010, he the advisor looks to Amedisys (AMED), a provider of home health care and hospice services.

Continue reading Top Picks for 2010: Amedisys (AMED)

Top Picks for 2010: Amedisys (AMED) originally appeared on BloggingStocks on Wed, 06 Jan 2010 16:00:00 EST. Please see our terms for use of feeds.

The Cabot Benjamin Graham Value Letter focuses on stocks that meet the strict value criteria of the legendary investor. Here, J. Royden Ward looks to Teva Pharmaceutical (NASDAQ: TEVA), noting, "Teva is based in Israel and develops, makes and sells generic and proprietary-branded (store brand) drugs."

The advisor explains, "The company is one of the largest generic drug-producing companies in the world and, in addition, sells active ingredients to other pharmaceutical companies.

"Teva's aggressive acquisition and product development programs are driving strong sales growth. The company recently purchased U.S.-based Barr Pharmaceuticals for $7.5 billion. Barr will increase Teva's generic drug sales significantly in the U.S. and parts of Europe.

Continue reading Teva: A 'Ben Graham' selection

Teva: A 'Ben Graham' selection originally appeared on BloggingStocks on Fri, 18 Sep 2009 13:30:00 EST. Please see our terms for use of feeds.

In The Cabot Benjamin Graham Value Letter, editor J. Royden Ward searches for stocks that meet the investing criteria of the legendary Ben Graham, known as the father of value investing and mentor of Warren Buffett.

Here, the advisor takes a look at Overseas Shipholding Group (NYSE: OSG), a crude oil and energy shipping operation.

"Overseas Shipholding is a leading crude oil and energy shipping company with 120 vessels either owned or leased. In addition, the company derives 25% of revenues from grain, coal, and iron ore.

Continue reading A 'Ben Graham value' in shipping

A 'Ben Graham value' in shipping originally appeared on BloggingStocks on Tue, 02 Jun 2009 10:40:00 EST. Please see our terms for use of feeds.

In The Cabot Benjamin Graham Value Letter -- which assesses stocks based on Graham's value investing critera, editor J. Royden Ward takes a look at Wal-Mart Stores (NYSE: WMT).

"In this month's Classic Benjamin Graham Value Model, our calculation suggests that the Dow is overvalued at 12,370 and undervalued at 8,305; as such, today the market is extremely undervalued.

"This low-risk environment means it's probably a great time to add risk by dabbling in our recommended stocks such as Wal-Mart Stores.

"How cheap is it? The recent decline in WMT shares has created an outstanding buying opportunity for investors. WMT shares now sell at only 12.3 times forward EPS with a dividend yield of 2.0%.

Continue reading Is Wal-Mart (WMT) now a value stock?

Is Wal-Mart (WMT) now a value stock? originally appeared on BloggingStocks on Thu, 26 Feb 2009 09:45:00 EST. Please see our terms for use of feeds.

"Stryker (NYSE: SYK) is a bargain at 15.1x next 12-month EPS," says J. Royden Ward, editor of The Cabot Benjamin Graham Value Letter, a service which focuses on stocks that would be well-suited to the investing strategy of Ben Graham, legendary value investor and mentor to Warren Buffett.

"Stryker develops, manufactures and sells specialty surgical and medical products. Its orthopedic division makes hip, knee and other implants.

"SYK also makes a wide variety of medical products and instruments ranging from hospital beds to medical video cameras, surgical drills and saws, and instruments for implants.

Continue reading Stryker (SYK): 'Hip' choice in surgical products

Stryker (SYK): 'Hip' choice in surgical products originally appeared on BloggingStocks on Thu, 29 Jan 2009 14:00:00 EST. Please see our terms for use of feeds.